Showing results (161-170 of 745) with videos related to

Sort By:
Pageof 75
Cardiology in Review|December 21, 2011
The evolution and refinement of traditional risk factors for cardiovascular diseaseEmil M deGoma, Joshua W Knowles, Fabio Angeli, et al.
Nature Clinical Practice. Cardiovascular Medicine|May 29, 2008
Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemiaFrederick F Samaha, James McKenney, Leanne T Bloedon, et al.
Journal of Lipid Research|August 1, 2006
Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-IIUli C Broedl, Weijun Jin, Ilia V Fuki, et al.
Journal of the American College of Cardiology|November 5, 2011
The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery diseaseParin J Patel, Amit V Khera, Kashif Jafri, et al.
Cardiovascular Drugs and Therapy|March 6, 2024
Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical TrialsRobert S Rosenson, Daniel J Rader, Shazia Ali, et al.
Journal of Lipid Research|December 10, 2008
The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosisDaniel J Rader, Eric T Alexander, Ginny L Weibel, et al.
Cardiovascular Research|August 25, 2025
Eicosapentaenoic acid (EPA) limits the more rapid oxidation of lipoprotein(a) [Lp(a)] compared with other ApoB particlesSamuel C R Sherratt, Peter Libby, Richard L Dunbar, et al.
Pageof 75